Efficient Wound Healing Using a Synthetic Nanofibrous Bilayer Skin Substitute in Murine Model.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
01 2020
Historique:
received: 24 07 2018
revised: 29 04 2019
accepted: 11 07 2019
pubmed: 11 8 2019
medline: 20 2 2020
entrez: 11 8 2019
Statut: ppublish

Résumé

Treatment of full-thickness skin wounds with minimal scarring and complete restoration of native tissue properties still exists as a clinical challenge. A bilayer skin substitute was fabricated by coating human amniotic membrane (AM) with electrospun silk fibroin nanofibers, and its in vivo biological behavior was studied using murine full-thickness skin wound model. Donut-shaped silicon splints were utilized to prevent wound contraction in mouse skin and simulate re-epithelialization, which is the normal path of human wound healing. Skin regeneration using the bilayer scaffold was compared with AM and untreated defect after 30 d. Tissue samples were taken from healed wound areas and investigated through histopathological and immunohistochemical staining to visualize involucrin (IVL), P63, collagen I, CD31, and vascular endothelial growth factor. In addition, mRNA expression of IVL, P63, interleukin-6, and cyclooxygenase-2 was studied. The application of bilayer scaffold resulted in the best epidermal and dermal regeneration, demonstrated by histopathological examination and molecular analysis. In regenerated wounds of the bilayer scaffold group, the mRNA expression levels of inflammatory markers (interleukin-6 and cyclooxygenase-2) were downregulated, and the expression pattern of keratinocyte markers (IVL and P63) at both mRNA and protein levels was more similar to native tissue in comparison with AM and no-treatment groups. There was no significant difference in the expression level of collagen I, CD31, and vascular endothelial growth factor among different groups. Conclusively, these promising results serve as a supporting evidence for proceeding to clinical phase to examine the capacity of this bilayer scaffold for human skin regeneration.

Identifiants

pubmed: 31400575
pii: S0022-4804(19)30511-6
doi: 10.1016/j.jss.2019.07.017
pii:
doi:

Substances chimiques

Fibroins 9007-76-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-44

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Shaghayegh Arasteh (S)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Sayeh Khanjani (S)

Division of Plastic Surgery, Department of Surgery, McGill University, Montreal, Quebec, Canada.

Hannaneh Golshahi (H)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Sahba Mobini (S)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Masoud Taghizadeh Jahed (MT)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Hamed Heidari-Vala (H)

Maisonneuve-Rosemont Hospital Research Center, Montreal, Quebec, Canada.

Haleh Edalatkhah (H)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Somaieh Kazemnejad (S)

Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. Electronic address: s.kazemnejad@ari.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH